Rewinding RX Review
Best for: Patients seeking a longevity / biological-age-reversal framing for their GLP-1 protocol (vs weight-loss-only positioning), who want MD-only clinical review (no PAs / NPs), LegitScript-verifiable certification, and flat-rate any-dose pricing — and who are comfortable signing up to see specific dollar amounts.
Rewinding RX (rewinding.com) is a longevity + anti-aging telehealth platform positioning GLP-1 within a broader 'biological age reversal' framework that also covers NAD+ and other functional-medicine protocols. Corporate entity disclosed as 'Rewinding RX Ltd.' Compounded semaglutide offered (injectable). Brand positioning: 'Complete Systems to Rewind Your Biological Age' with 'Longevity Physicians' framing. Pricing model: 'ONE FLAT MONTHLY PRICE' covering 'Any dose level' with free express shipping, no membership fees, no cancellation fees — but specific dollar amounts NOT disclosed on public-facing pages. Available in all 50 states. Physician network: '85+ licensed physicians across the United States' with verbatim disclosure: 'Every case reviewed by a fully licensed MD — never a physician assistant or nurse' and 'Patients matched to physicians licensed in their state.' LegitScript Certified with verifiable ID 43188279. Both 503A and 503B compounding pharmacy types mentioned generically (no specific partner named). Verbatim FDA disclaimer: 'The FDA does not review or approve any compounded medications for safety or effectiveness.' Cancel anytime. Live-verified 2026-05-19.
High confidence · Last verified 2026-05-19 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Rewinding RX is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Rewinding RX prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
✓ Pros
- •LegitScript Certified with publicly visible ID (43188279) — verifiable signal beyond just the badge
- •Verbatim FDA compounded-medication disclaimer published — uncommon transparency
- •MD-only physician network ('never a physician assistant or nurse') is a strong differentiation vs marketplace platforms using mid-level providers
- •All-50-state coverage with explicit physician state-licensing matching
- •Corporate entity disclosed (Rewinding RX Ltd.) — better than many DTC competitors
- •Flat-rate any-dose pricing model removes the common 'price escalates as you titrate up' frustration in the DTC market
- •No-cancellation-fee framing reduces sign-up friction
- •Longevity positioning is differentiated and appeals to a higher-LTV biological-age-focused buyer segment vs weight-loss-only competitors
✗ Cons
- •Specific pricing dollar amounts NOT disclosed publicly — fully gated behind sign-up flow
- •Pharmacy partner NOT named (only generic '503A pharmacies' / '503B pharmacies' references)
- •Named medical director / clinical leadership NOT disclosed
- •Governing law / arbitration venue / corporate physical address NOT disclosed
- •Tirzepatide availability NOT explicitly listed on the main homepage (semaglutide only confirmed)
- •Longevity / biological-age positioning may dilute weight-loss clinical focus vs specialist GLP-1 providers
- •85+ physician count is a generic claim — no roster, no individual credentials browsable
Ready to start with Rewinding RX?
See current pricing and start your free consultation.
Sources & methodology
Our Rewinding RX review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Alternatives to Rewinding RX
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Rewinding RX?
See current pricing and start your free consultation.